Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: A pilot study

Respiratory Medicine

Volumn 106, Issue 10, 2012, Pages 1369-1375

  Cai, Chuang ^a,b   He, Mu Zhi ^c   Zhong, Shu Qing ^b   Tang, Yan ^b   Sun, Bao Qing ^b   Chen, Qiao Li ^b   Zhong, Nan Shan ^b  

^a HANGZHOU RED CROSS HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Airway eosinophilia; Budesonide; Chronic cough; Cough visual analogue scale; Montelukast; Nonasthmatic eosinophilic bronchitis

Indexed keywords

BUDESONIDE; MONTELUKAST;

ADD ON THERAPY; ADULT; AGE; AGED; AIRWAY EOSINOPHILIA; ARTICLE; BRONCHITIS; CONTROLLED STUDY; COUGH VISUAL ANALOGUE SCALE; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EOSINOPHIL; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NONASTHMATIC EOSINOPHILIC BRONCHITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; VISUAL ANALOG SCALE;

ACETATES; ADULT; AGED; BRONCHITIS; BRONCHODILATOR AGENTS; BUDESONIDE; CHRONIC DISEASE; COUGH; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY EOSINOPHILIA; QUINOLINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865269467     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.06.009     Document Type: Article

References (32)

1. C.E. Brightling Chronic cough due to nonasthmatic eosinophilic bronchitis. ACCP evidence-based clinical practice guidelines Chest 129 2006 116S 121S (Pubitemid 43265212)
2. C.E. Brightling, R. Ward, K.L. Goh, A.J. Wardlaw, and I.D. Pavord Eosiniphilic bronchitis is an important cause of chronic cough Am J Respir Crit Care Med 160 1999 406 410 (Pubitemid 29380649)
3. U. Gonlugur, and T.E. Gonlugur Eosinophilic bronchitis without asthma Int Arch Allergy Immunol 147 2008 1 5
4. C.E. Brightling, R. Ward, A.J. Wardlaw, and I.D. Pavord Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis Eur Respir J 15 2000 682 686 (Pubitemid 30196295)
5. S.W. Park, Y.M. Lee, A.S. Jang, J.H. Lee, Y. Hwangbo, D.J. Kim, and C.S. Park Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study Chest 125 2004 1998 2004 (Pubitemid 38788162)
6. M.A. Berry, B. Hargadon, and S. McKenna Observational study of the natural history of eosinophilic bronchitis Clin Exp Allergy 35 2005 598 601 (Pubitemid 40769283)
7. P.G. Gibson, F.E. Hargreave, A. Girgis-Gabardo, M. Morris, J.A. Denburg, and J. Dolovich Chronic cough: eosinophilic bronchitis without asthma Lancet 1 1989 1346 1348 (Pubitemid 19151953)
8. S.S. Birring, M. Berry, C.E. Brightling, and I.D. Pavord Eosinophilic bronchitis: clinical features, management and pathogenesis Am J Respir Med 2 2003 169 173 (Pubitemid 37062725)
9. Y. Ogawa, and W.J. Calhoun The role of leukotrienes in airway inflammation J Allergy Clin Immunol 118 2006 789 798 (Pubitemid 44498776)
10. W. Busse, and M. Kraft Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy Chest 127 2005 1312 1326 (Pubitemid 46224296)
11. D.B. Price, D. Hernandez, and P. Magyar Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Thorax 58 2003 211 216 (Pubitemid 36307998)
12. G.C. Jat, J.L. Mathew, and M. Singh Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial Ann Allergy Asthma Immunol 97 2006 397 401 (Pubitemid 44476578)
13. N. Barnes, M. Laviolette, and D. Allen Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control Respir Med 101 2007 1652 1658 (Pubitemid 46937915)
14. C.E. Brightling, R. Ward, G. Woltmann, P. Bradding, J.R. Sheller, R. Dworski, and I.D. Pavord Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma Am J Respir Crit Care Med 162 2000 878 882
15. S.S. Birring, D. Parker, C.E. Brightling, P. Bradding, A.J. Wardlaw, and I.D. Pavord Induced sputum inflammatory mediator concentrations in chronic cough Am J Respir Crit Care Med 169 2004 15 19 (Pubitemid 38236160)
16. W. Luo, K.F. Lai, and R.C. Chen Characteristics of airway inflammatory cells and mediators in eosinophilic bronchitis patients Chin J Tuberc Respir Dis 28 2005 626 629 [In Chinese] (Pubitemid 44763513)
17. GINA Report, Global strategy for asthma management and prevention. (Updated December 2010) http://www.ginasthma.org/.
18. M.R. Pratter, C.E. Brightling, L.P. Boulet, and R.S. Irwin An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines Chest 129 2006 222S 231S (Pubitemid 43265226)
19. J. Xie, Q. Zhang, N. Zhong, and K. Lai BAL fluid 8-isoprostane concentrations in eosinophilic bronchitis and asthma J Asthma 46 2009 712 715
20. M.R. Pratter Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines Chest 129 2006 63S 71S (Pubitemid 43265206)
21. R.S. Irwin Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines Chest 129 2006 80S 94S (Pubitemid 43265209)
22. R.S. Irwin Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines Chest 129 2006 232S 237S (Pubitemid 43265227)
23. P.G. Gibson, F.E. Hargreave, A. Girgis-Gabardo, M. Morris, J.A. Denburg, and J. Dolovich Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid Clin Exp Allergy 25 1995 127 132
24. P.V. Dicpinigaitis, J.B. Dobkin, and J. Reichel Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma J Asthma 39 2002 291 297 (Pubitemid 34671102)
25. S.L. Spector, and R.A. Tan Effectiveness of montelukast in the treatment of cough variant asthma Ann Allergy Asthma Immunol 93 2004 232 236 (Pubitemid 39280525)
26. T. Kita, M. Fujimura, and H. Ogawa Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough Allergol Int 59 2010 185 192
27. D. Desai, and C. Brightling Cough due to asthma, cough-variant asthma and non-asthmatic eosinophilic bronchitis Otolaryngol Clin North Am 43 2010 123 130
28. C.E. Brightling Cough due to asthma and nonasthmatic eosinophilic bronchitis Lung 188 Suppl. 1 2010 S13 S17
29. J.C. Virchow, and C. Bachert Efficacy and safety of montelukast in adults with asthma and allergic rhinitis Respir Med 100 2006 1952 1959 (Pubitemid 44490289)
30. G. Riccioni, T. Bucciarelli, B. Mancini, C. Di Ilio, and N. D'Orazio Antileukotriene drugs: clinical application, effectiveness and safety Curr Med Chem 14 2007 1966 1977 (Pubitemid 47209107)
31. D. Price Tolerability of montelukast Drugs 59 Suppl. 1 2000 35 42 (Pubitemid 30179167)
32. R.S. Irwin, and N.D. Richardson Side effects with inhaled corticosteroids: the physician's perception Chest 130 1 Suppl. 2006 41S 53S (Pubitemid 44107235)